Stay updated on Nivolumab and Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding lapse notice about NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe Study Record Dates section now includes additional update timestamps (e.g., 2025-10-29, 2026-04-06, 2026-10-06, 2025-10-28) and updates the label to Last Update Posted (Estimated).SummaryDifference0.8%

- Check71 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check78 days agoChange Detected- Updated the revision tag from v3.0.2 to v3.1.0, indicating a new version. No substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.